ARTL
Price
$4.51
Change
+$0.16 (+3.68%)
Updated
Sep 5 closing price
Capitalization
5.96M
PALI
Price
$0.63
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
5.84M
Interact to see
Advertisement

ARTL vs PALI

Header iconARTL vs PALI Comparison
Open Charts ARTL vs PALIBanner chart's image
Artelo Biosciences
Price$4.51
Change+$0.16 (+3.68%)
Volume$235.5K
Capitalization5.96M
Palisade Bio
Price$0.63
Change-$0.00 (-0.00%)
Volume$5.05M
Capitalization5.84M
ARTL vs PALI Comparison Chart in %
Loading...
ARTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PALI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARTL vs. PALI commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARTL is a Hold and PALI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (ARTL: $4.51 vs. PALI: $0.63)
Brand notoriety: ARTL and PALI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARTL: 71% vs. PALI: 173%
Market capitalization -- ARTL: $5.96M vs. PALI: $5.84M
ARTL [@Biotechnology] is valued at $5.96M. PALI’s [@Biotechnology] market capitalization is $5.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARTL’s FA Score shows that 0 FA rating(s) are green whilePALI’s FA Score has 1 green FA rating(s).

  • ARTL’s FA Score: 0 green, 5 red.
  • PALI’s FA Score: 1 green, 4 red.
According to our system of comparison, PALI is a better buy in the long-term than ARTL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARTL’s TA Score shows that 4 TA indicator(s) are bullish while PALI’s TA Score has 4 bullish TA indicator(s).

  • ARTL’s TA Score: 4 bullish, 6 bearish.
  • PALI’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both ARTL and PALI are a bad buy in the short-term.

Price Growth

ARTL (@Biotechnology) experienced а -51.24% price change this week, while PALI (@Biotechnology) price change was -7.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARTL($5.96M) and PALI($5.84M) have the same market capitalization . ARTL YTD gains are higher at: -29.088 vs. PALI (-62.030). ARTL has higher annual earnings (EBITDA): -10.71M vs. PALI (-11.83M). PALI has more cash in the bank: 5.42M vs. ARTL (2.07M). PALI has less debt than ARTL: PALI (338K) vs ARTL (878K). ARTL (0) and PALI (0) have equivalent revenues.
ARTLPALIARTL / PALI
Capitalization5.96M5.84M102%
EBITDA-10.71M-11.83M91%
Gain YTD-29.088-62.03047%
P/E RatioN/A0.02-
Revenue00-
Total Cash2.07M5.42M38%
Total Debt878K338K260%
FUNDAMENTALS RATINGS
ARTL vs PALI: Fundamental Ratings
ARTL
PALI
OUTLOOK RATING
1..100
5950
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
28
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9593
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
833

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PALI's Valuation (28) in the null industry is somewhat better than the same rating for ARTL (61). This means that PALI’s stock grew somewhat faster than ARTL’s over the last 12 months.

PALI's Profit vs Risk Rating (100) in the null industry is in the same range as ARTL (100). This means that PALI’s stock grew similarly to ARTL’s over the last 12 months.

PALI's SMR Rating (100) in the null industry is in the same range as ARTL (100). This means that PALI’s stock grew similarly to ARTL’s over the last 12 months.

PALI's Price Growth Rating (93) in the null industry is in the same range as ARTL (95). This means that PALI’s stock grew similarly to ARTL’s over the last 12 months.

PALI's P/E Growth Rating (100) in the null industry is in the same range as ARTL (100). This means that PALI’s stock grew similarly to ARTL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARTLPALI
RSI
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
78%
Bullish Trend 16 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ARTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PALI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EPAC42.690.32
+0.76%
Enerpac Tool Group Corp
ZVRA8.950.02
+0.22%
Zevra Therapeutics
H144.95-0.33
-0.23%
Hyatt Hotels Corp
STKH0.65-0.02
-2.51%
Steakholder Foods Ltd
GRWG1.51-0.04
-2.58%
GrowGeneration Corp

ARTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARTL has been loosely correlated with MTNB. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ARTL jumps, then MTNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARTL
1D Price
Change %
ARTL100%
+3.68%
MTNB - ARTL
37%
Loosely correlated
+1.78%
PALI - ARTL
34%
Loosely correlated
-0.98%
APLM - ARTL
31%
Poorly correlated
-5.84%
IGC - ARTL
30%
Poorly correlated
-0.98%
PHIO - ARTL
28%
Poorly correlated
-0.97%
More

PALI and

Correlation & Price change

A.I.dvisor indicates that over the last year, PALI has been closely correlated with CDTX. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if PALI jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PALI
1D Price
Change %
PALI100%
-0.98%
CDTX - PALI
82%
Closely correlated
-2.71%
TAOX - PALI
81%
Closely correlated
+6.91%
NCNA - PALI
81%
Closely correlated
+0.35%
NBY - PALI
80%
Closely correlated
-11.61%
AGEN - PALI
80%
Closely correlated
+0.93%
More